We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 88 results
  1. Prognostic effect of lncRNA SNHG7 on cancer outcome: a meta and bioinformatic analysis

    Background

    New evidence from clinical and fundamental researches suggests that SNHG7 is involved in the occurrence and development of carcinomas. And...

    Yunyuan Zhang, Qingwu Tian, ... **an Chen in BMC Cancer
    Article Open access 03 January 2022
  2. RETRACTED ARTICLE: Long non-coding RNA SNHG7 upregulates FGF9 to alleviate oxygen and glucose deprivation-induced neuron cell injury in a miR-134-5p-dependent manner

    Long non-coding RNA small nucleolar RNA host gene 7 (SNHG7) was reported to regulate the pathogenesis of ischemic stroke. The study aimed to disclose...

    Wei Sun, Lu Sun, ... Shubei Ma in Metabolic Brain Disease
    Article 18 October 2021
  3. LncRNA SNHG7 sponges miR-449a to promote pituitary adenomas progression

    This study aimed to characterize the expression status and potentially mechanistic involvement of SNHG7 in pituitary adenoma. Relative expression of...

    **ongfei Yue, Ce Dong, ... Baogen Pan in Metabolic Brain Disease
    Article 03 September 2020
  4. LncRNA SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis

    Background

    Nasopharyngeal carcinoma (NPC), with distinct geographical distribution, has gathered public attention. Despite that radiotherapy and...

    Weiqun Hu, Haolin Li, Shaozhong Wang in BMC Cancer
    Article Open access 05 May 2020
  5. Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

    Background

    Fatty acid (FA) metabolism is considered the emerging cause of tumor development and metastasis, driving poor prognosis. Long non-coding...

    Erbao Chen, **g Yi, ... Jikui Liu in BMC Cancer
    Article Open access 04 October 2022
  6. Metformin and long non-coding RNAs in breast cancer

    Breast cancer (BC) is the second most common cancer and cause of death in women. In recent years many studies investigated the association of long...

    Morteza Gholami, Zeynab Nickhah Klashami, ... Mahsa M. Amoli in Journal of Translational Medicine
    Article Open access 27 February 2023
  7. Modulation of Long Non-coding RNAs in Cancer

    Cancer is associated to uncontrolled growth of cells. It is the second most common cause of death worldwide. Main treatment consists of surgery,...
    Glenda Nicioli da Silva, Lívia da Cunha Agostini, Tamires Cunha Almeida in Handbook of Cancer and Immunology
    Living reference work entry 2024
  8. Long noncoding RNAs: functions and mechanisms in colon cancer

    Evidence indicates that long non-coding RNAs (lncRNAs) play a crucial role in the carcinogenesis and progression of a wide variety of human...

    Sian Chen, **an Shen in Molecular Cancer
    Article Open access 28 November 2020
  9. Construction of CeRNA regulatory network based on WGCNA reveals diagnosis biomarkers for colorectal cancer

    Background

    Colorectal cancer is the third most common cause of death among cancers in the world. Although improvements in various treatments have...

    Jun **ang, Li Gao, ... Gui Yu Wang in BMC Cancer
    Article Open access 17 September 2022
  10. Joint analysis of lncRNA m6A methylome and lncRNA/mRNA expression profiles in gastric cancer

    Background

    N 6 -methyladenosine (m 6 A) modification might be closely associated with the genesis and development of gastric cancer (GC). Currently, the...

    Zhi Lv, Li** Sun, ... Yuan Yuan in Cancer Cell International
    Article Open access 25 September 2020
  11. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer

    Background

    The lack of distinct biomarkers for pancreatic cancer is a major cause of early-stage detection difficulty. The pancreatic cancer patient...

    Baek Gil Kim, Sung Hwan Lee, ... Nam Hoon Cho in Journal of Translational Medicine
    Article Open access 13 May 2024
  12. The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target

    The incidence of prostate cancer (PCa), the most prevalent malignancy, is currently at the forefront. RNA modification is a subfield of the booming...

    Xuming Zhou, Keqiang Chai, ... Guoxi Zhang in BMC Cancer
    Article Open access 02 January 2024
  13. Interaction of lncRNAs with mTOR in colorectal cancer: a systematic review

    Colorectal cancer (CRC) is the third most widespread cancer and the fourth leading lethal disease among different societies. It is thought that CRC...

    Marziyeh Sadat Moslehian, Roya Shabkhizan, ... Ebrahim Sakhinia in BMC Cancer
    Article Open access 06 June 2023
  14. The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets

    Neuroblastoma (NB) is a malignant tumor in young children that originates from the neural crest of the sympathetic nervous system. Generally, NB...

    Shaohui Huang, Naying Gong, ... Hua Zhang in Biomarker Research
    Article Open access 07 April 2022
  15. PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression

    Surgery and chemo-radiotherapy are used as the common first-line treatment options in many cancers. However, tumor relapse is observed in many cancer...

    Negin Taghehchian, Amirhosein Maharati, ... Meysam Moghbeli in Cancer Cell International
    Article Open access 08 October 2023
  16. Emerging role of RNA modification and long noncoding RNA interaction in cancer

    RNA modification, especially N6-methyladenosine, 5-methylcytosine, and N7-methylguanosine methylation, participates in the occurrence and progression...

    Liqiong Yang, Lu Tang, ... **g Shen in Cancer Gene Therapy
    Article Open access 14 February 2024
  17. Current concepts of microRNA-mediated regulatory mechanisms in human pulp tissue-derived stem cells: a snapshot in the regenerative dentistry

    One of the most studied class of non-coding RNAs is microRNAs (miRNAs) which regulate more than 60% of human genes. A network of miRNA gene...

    Mohammad Hasan Soheilifar, Sima Nobari, ... Hoda Keshmiri Neghab in Cell and Tissue Research
    Article 29 May 2023
  18. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC

    Background

    Non-small cell lung cancer (NSCLC) is the most prevalent type of lung carcinoma with an unfavorable prognosis. Ferroptosis is involved in...

    Meng Li, Yanpeng Zhang, ... Puyu Shi in BMC Medical Genomics
    Article Open access 03 December 2021
  19. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia

    Background

    N6-methyladenosine (m6A) has been confirmed to function critically in acute myeloid leukemia (AML) progression. Hitherto, the subty** and...

    Caizhu Fu, Ruirui Kou, ... Min Dong in BMC Medical Genomics
    Article Open access 18 August 2023
Did you find what you were looking for? Share feedback.